Yuta Kochi Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

6/2022	Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis.
6/2022	47XXY and 47XXX in Scleroderma and Myositis.
5/2022	Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study.
1/2022	Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
1/2022	Anti-Double-Stranded DNA Antibodies Recognize DNA Presented on HLA Class II Molecules of Systemic Lupus Erythematosus Risk Alleles.
1/2019	PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes.
1/2019	Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.
7/2013	An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes.
2/2010	The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuta Kochi Research Topics

Disease

26	Rheumatoid Arthritis 01/2021 - 12/2003
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2022 - 02/2010
9	Autoimmune Diseases (Autoimmune Disease) 06/2022 - 07/2008
3	Arthritis (Polyarthritis) 01/2021 - 01/2006
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 05/2009
2	Inflammation (Inflammations) 01/2019 - 07/2011
2	Experimental Arthritis 01/2016 - 01/2006
1	Klinefelter Syndrome (Klinefelter's Syndrome) 06/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 06/2022
1	Systemic Scleroderma (Systemic Sclerosis) 06/2022
1	Genetic Risk Score 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Herpes Zoster 01/2021
1	Ulcerative Colitis 01/2021
1	Psoriatic Arthritis 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Necrosis 01/2021
1	Osteoarthritis 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Lymphadenopathy 01/2019
1	Stroke (Strokes) 01/2019
1	Splenomegaly 01/2019
1	Takayasu Arteritis (Arteritis, Takayasu's) 12/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Neoplasms (Cancer) 02/2014
1	Disease Susceptibility (Diathesis) 07/2008
1	Colitis 01/2006

Drug/Important Bio-Agent (IBA)

12	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2004
5	CytokinesIBA 01/2021 - 12/2003
3	Biological ProductsIBA 05/2022 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2010
3	AutoantibodiesIBA 01/2022 - 01/2018
3	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 12/2009
3	EpitopesIBA 01/2018 - 01/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 01/2006
2	InterferonsIBA 06/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 04/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 02/2014
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2010
2	Amino Acids FDA Link 08/2016 - 05/2015
2	cyclic citrullinated peptideIBA 08/2010 - 12/2009
2	Fc Receptors (Fc Receptor)IBA 11/2009 - 05/2005
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Complement System Proteins (Complement)IBA 06/2022
1	SteroidsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	tofacitinibIBA 01/2021
1	ChemokinesIBA 01/2021
1	HomocysteineIBA 01/2019
1	anti-dsDNA autoantibodyIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	HLA-B Antigens (HLA-B)IBA 12/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Collagen Type II (Type II Collagen)IBA 01/2016
1	Protein-Arginine Deiminase Type 4IBA 01/2016
1	acetyl 4-aminosalicylic acidIBA 05/2015
1	Peptides (Polypeptides)IBA 04/2015
1	AutoantigensIBA 07/2011
1	arginine deiminaseIBA 03/2011
1	SialomucinsIBA 02/2011
1	CC ChemokinesIBA 06/2010
1	Interleukin-17 (Interleukin 17)IBA 06/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2010
1	LuciferasesIBA 10/2008
1	ORALIT (ORS)IBA 07/2008
1	CollagenIBA 01/2006
1	Messenger RNA (mRNA)IBA 01/2006
1	Sulfonic AcidsIBA 01/2006
1	CationsIBA 12/2003

Therapy/Procedure

1	Therapeutics 01/2017